HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoya Kato Selected Research

lomofungin

11/2018Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoya Kato Research Topics

Disease

55Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2002
31Neoplasms (Cancer)
10/2022 - 07/2004
25Infections
10/2022 - 04/2001
12Fibrosis (Cirrhosis)
10/2022 - 01/2003
11Chronic Hepatitis C
10/2022 - 12/2004
10Liver Cirrhosis (Hepatic Cirrhosis)
05/2019 - 01/2004
6Liver Neoplasms (Liver Cancer)
09/2022 - 11/2002
6Acute Liver Failure (Fulminant Hepatic Failure)
01/2022 - 01/2018
5Liver Diseases (Liver Disease)
05/2022 - 07/2002
5Pancreatic Neoplasms (Pancreatic Cancer)
12/2020 - 11/2002
4Disease Progression
01/2022 - 04/2018
4Stomach Neoplasms (Stomach Cancer)
09/2020 - 11/2002
4Chronic Hepatitis (Chronic Active Hepatitis)
11/2018 - 12/2004
4Inflammation (Inflammations)
06/2018 - 12/2004
4Hepatitis B
06/2018 - 04/2001
3Ulcerative Colitis
11/2022 - 12/2018
3Carcinoma (Carcinomatosis)
09/2022 - 01/2017
3Alcoholism (Alcohol Abuse)
05/2022 - 11/2016
3Hemorrhage
05/2022 - 01/2019
3Liver Failure
12/2021 - 01/2018
3Neoplasm Metastasis (Metastasis)
04/2021 - 10/2018
3Type 2 Diabetes Mellitus (MODY)
12/2020 - 01/2012
3Carcinogenesis
01/2017 - 04/2005
3Virus Diseases (Viral Diseases)
01/2012 - 03/2006
2Crohn Disease (Crohn's Disease)
11/2022 - 08/2019
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2022 - 01/2020
2Non-alcoholic Fatty Liver Disease
10/2022 - 01/2020
2Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2022 - 01/2021
2Adenocarcinoma
04/2021 - 05/2020
2Massive Hepatic Necrosis
04/2021 - 02/2019
2Gastroesophageal Reflux (GERD)
01/2020 - 01/2018
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
06/2019 - 01/2017
2Autoimmune Hepatitis
01/2019 - 02/2018
2Colonic Neoplasms (Colon Cancer)
10/2018 - 11/2002
2Pathologic Constriction (Stenosis)
06/2018 - 01/2018
2Hepatitis C
04/2012 - 06/2006
2Chronic Hepatitis B
01/2012 - 04/2001
1Diverticulum
12/2022

Drug/Important Bio-Agent (IBA)

13Antiviral Agents (Antivirals)IBA
01/2022 - 04/2001
13InterferonsIBA
07/2021 - 07/2002
11micaIBA
04/2022 - 01/2012
10Biomarkers (Surrogate Marker)IBA
09/2022 - 12/2004
9Sorafenib (BAY 43-9006)FDA Link
11/2021 - 01/2018
9Proteins (Proteins, Gene)FDA Link
01/2021 - 02/2002
8Pharmaceutical PreparationsIBA
10/2022 - 02/2003
8Peptides (Polypeptides)IBA
09/2022 - 12/2004
5BilirubinIBA
05/2022 - 04/2018
5regorafenibIBA
04/2022 - 01/2018
5alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2022 - 01/2003
4Immune Checkpoint InhibitorsIBA
01/2022 - 09/2020
4Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 06/2018
4lenvatinibIBA
09/2021 - 04/2020
4Complementary DNA (cDNA)IBA
01/2021 - 11/2002
4Phosphotransferases (Kinase)IBA
01/2021 - 09/2005
4CytokinesIBA
01/2019 - 01/2003
4LigandsIBA
10/2018 - 03/2015
4Serum AlbuminIBA
06/2018 - 08/2006
4DNA (Deoxyribonucleic Acid)IBA
04/2018 - 08/2002
4MicroRNAs (MicroRNA)IBA
01/2017 - 07/2014
3Biological ProductsIBA
11/2022 - 03/2020
3SofosbuvirIBA
10/2022 - 01/2018
3Liposomes (Liposome)IBA
09/2022 - 10/2018
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022 - 01/2003
3AlbuminsIBA
05/2022 - 12/2004
3GemcitabineFDA Link
01/2022 - 01/2018
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 11/2002
3Alanine Transaminase (SGPT)IBA
11/2021 - 10/2009
3RNA (Ribonucleic Acid)IBA
01/2019 - 04/2005
3Lamivudine (Epivir)FDA Link
09/2008 - 04/2001
2velpatasvirIBA
10/2022 - 01/2021
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 11/2021
2Immunoglobulin G (IgG)IBA
01/2021 - 03/2018
2Proton Pump InhibitorsIBA
02/2020 - 01/2020
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
11/2019 - 01/2005
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
06/2019 - 01/2017
2MetalsIBA
07/2018 - 06/2018
2NucleosidesIBA
06/2018 - 04/2001
2Disulfiram (Antabuse)FDA Link
04/2018 - 11/2016
2Indicators and Reagents (Reagents)IBA
01/2018 - 08/2008
2Histone Deacetylase InhibitorsIBA
01/2017 - 12/2016
2Transforming Growth Factors (Transforming Growth Factor)IBA
11/2016 - 01/2004
2Hepatitis B e AntigensIBA
09/2012 - 01/2012
2Ribavirin (Virazole)FDA LinkGeneric
04/2012 - 06/2006
2Interferon-alpha (Interferon Alfa)IBA
11/2004 - 04/2001
2Fluorouracil (Carac)FDA LinkGeneric
11/2004 - 11/2002
2Interleukin-1beta (Interleukin 1 beta)IBA
04/2004 - 01/2003

Therapy/Procedure

34Therapeutics
09/2022 - 04/2001
5Drug Therapy (Chemotherapy)
01/2021 - 11/2004
4Liver Transplantation
04/2021 - 01/2019
3Stents
10/2022 - 10/2021
2Precision Medicine
09/2022 - 03/2015
2Immunotherapy
01/2022 - 03/2015
2Combination Drug Therapy (Combination Chemotherapy)
01/2022 - 11/2004
2Catheters
09/2021 - 01/2018
2Duration of Therapy
09/2021 - 12/2018
2Radiofrequency Ablation
02/2021 - 04/2018
2Pancreatectomy
12/2020 - 01/2020
2Endoscopic Sphincterotomy
10/2020 - 10/2018
2Renal Dialysis (Hemodialysis)
10/2020 - 01/2019
2Retreatment
03/2018 - 01/2018